U.S. exports of Human Blood, Prepared Animal Blood, Toxins & Microbial Cultures (SITC 54164) totaled $413.3M in September 2026.
Importers of Human Blood, Prepared Animal Blood, Toxins & Microbial Cultures paid $298K in duties in September 2026, an average duty rate of 0.11% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Human Blood, Prepared Animal Blood, Toxins & Microbial Cultures imports of $279.0M in September 2026 ran 34% above the year-to-date monthly average of $208.5M.
Last updated: September 2026 dataHuman blood, animal blood prepared for therapeutic or diagnostic use, microbial toxins, and cultures of micro-organisms (excluding yeasts) occupy a uniquely sensitive regulatory space — combining FDA oversight for human biologics with biosafety and biosecurity considerations for pathogenic cultures. Certain microbial cultures and toxins are classified as select agents under the CDC/USDA Select Agent Program, requiring registration and strict transfer controls that go well beyond standard customs entry procedures. Importers of diagnostic microbial cultures should confirm whether the specific organism or toxin appears on the select agent list before arranging shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
1.8K import shipments a month
Organisms and toxins listed as select agents — including certain bacterial toxins and pathogenic cultures — require that both the importer and the receiving facility be registered with the CDC or USDA Select Agent Program. Shipments of select agents must be pre-authorized, and unauthorized possession or transfer carries severe civil and criminal penalties. Importers should screen the specific organism or toxin against the current select agent list before initiating any import.
Yes. Human blood and its components are regulated as biologics by FDA CBER, while prepared animal blood for diagnostic or research use may fall under different FDA pathways or, if intended for veterinary therapeutic use, USDA oversight. The intended end use — human therapeutic, veterinary, or in vitro diagnostic — determines which regulatory framework and admissibility review applies.
Basic heading 12 of 465 in section 5
Basic heading 54164 · $413.3M of $26.2B
Trade Directory
List your company and tag the 6-digit products you trade, so the companies trading them can find you. Be the first supplier listed.
ImportsExports
Imports
$279.0MYoY · free account
Exports
$413.3MYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to September 2026, the U.S. imported $2.6B of Human Blood, Prepared Animal Blood, Toxins & Microbial Cultures and exported $4.3B.
Through September 2026. Source: U.S. Census Bureau.
Exports · September 2026
destination
customs district
Census does not publish district detail for this classification system.
origin
Census does not publish state detail for this classification system.
entry
Census does not publish port detail for this classification system.